Stem Cells therapy to Reverse Type 1 Diabetes

Diabetes treatment with stem cell therapyPrevious studies, especially the ones led by researchers of the University of Sao Paulo and Northwestern University in Chicago, have shown that it is possible to successfully treat type 1 diabetes using stem cells. A major part of the individuals who received this adult stem cell treatment witnessed an appreciable repopulation of functioning insulin-producing beta cells in the pancreas.

The A1StemCells most recent results using the most powerful stem cells which are the Embryonic Stem Cells not only confirmed the possibility to reverse diabetes by developing new beta cells but also showed that new blood vessels were formed in the process within the pancreas. This additional supply of blood allows for a better functioning of all the beta cells – new and old ones-  and led to a natural increase of insulin production.

According to the Journal of the American Medical Association, diabetes type 1 now affects nearly 8% of adults and children who are told that there is no cure. “ Although it is too soon to say that we cure diabetes type 1 as we don’t have at least 5 years since our first successful treatment, it is possible to say that we are changing the way this disease is perceived as most of our patients are able to live without depending on insulin or immune depression medication”.

It is the patient’s own immune system that turns on the beta cells that produce insulin and leads to diabetes type 1. When the immune cells have virtually eliminated all of the body’s beta cells, the glucose levels starts to climb and that’s when the disease is detected. Most researchers have no clue about what triggers this attack and only proposes to counter the immune system with medication or wipe it out and replace it with a fresh one. Our strategy for diabetes cure followed a different path as we wanted to remove the cause of the immune system attack first before restoring the damaged pancreas with stem cells.

Different studies have shown that diabetes victims all present similar pollutants in their pancreas and digestive system as well as react to similar allergens. Through the years of study, we have been able to confirm the presence of these pollutants and parasites and define a protocol to selectively remove them from the body in order to first stop the immune system hyperactivity. Such selective cleanse requires between 10 to 21 daily IV treatments, depending on the results of the tests performed upon arrival of the patient. The selective removal of these pollutants usually allows the pancreas to already improve its insulin production by 15%.

Once the body is cleared from what causes the immune response, the stem cell therapy is introduced in the protocol. The amount of stem cells and the frequency of the treatments will be determined according to the level of damages that have to be repaired, the overall health of the patient and the duration of the disease since it has been diagnosed. A minimum of 2 injections is usually required to promote the formation of new beta cells and blood vessels within the pancreas and start the production of insulin.

Within 3 weeks after the beginning of the treatment, we are most of the time able to measure increased blood levels of  the  protein, C-peptide, that is produced by beta cells, showing an increase in the population of insulin production cells.

Among the 31 patients who were all dependent on supplemental insulin, levels of C-peptide rose in 28 of them and remained stable. 21 were able to stay off insulin supplementation for two years after following our protocol, and ten needed only intermittent help from insulin.

Patients usually need to stay at the clinic for 3h a day during which IV treatments and tests are performed. Depending on the initial results, a specific diet maybe recommended along the cleanse program. Embryonic Stem Cells treatments usually start on the 7th day of the stay. They are usually infused into the blood stream.

During this time, the patients’ insulin needs to be monitored as their need for external insulin gradually reduces.

This study is the first to combine both personalized cleanse and embryonic stem cell therapy for type 1 diabetes patients and is a milestone in diabetes therapy, providing a life-changing alternative to a growing population that is locked in a constant struggle to manage their blood’s glucose levels. Although all patients will benefit from the A1StemCells treatment, it is recommended for those who have just been diagnosed to not wait too long as the sooner the immune system’s attack is stopped, the easier it is to restart the insulin production.

Comments are closed.